Advertisement
Screener

Eagle Pharmaceuticals, Inc. Total Assets

Eagle Pharmaceuticals, Inc. Total Assets

Eagle Pharmaceuticals, Inc. had Total Assets of $404.82 million as of 2023-06-30, per its 10-Q/A filed 2023-08-09.

Discontinued › Balance Sheet › Assets

us-gaap:Assets · last filed 2023-08-09

  • 2023-06-30: Assets $404.82M.
  • 2023-03-31: Assets $414.18M.
  • 2022-12-31: Assets $406.16M.
  • 2022-09-30: Assets $386.45M.
Period endAssetsAssets as first filed
2023-06-30$404.82M
10-Q/A · filed 2023-08-09
2023-03-31$414.18M
10-Q · filed 2023-05-09
2022-12-31$406.16M
10-Q/A · filed 2023-08-09
2022-09-30$386.45M
10-Q · filed 2022-11-09
2022-06-30$381.76M
10-Q · filed 2022-08-09
2022-03-31$320.17M
10-Q · filed 2022-05-09
2021-12-31$253.73M
10-K · filed 2023-03-23
2021-09-30$256.26M
10-Q · filed 2021-11-09
2021-06-30$264.24M
10-Q · filed 2021-08-09
2021-03-31$259.97M
10-Q · filed 2021-05-10
2020-12-31$253.19M
10-K · filed 2022-03-08
2020-09-30$248.16M
10-Q · filed 2020-11-02
2020-06-30$256.71M
10-Q · filed 2020-08-10
2020-03-31$361.94M
10-Q · filed 2020-05-11
2019-12-31$254.55M
10-K · filed 2021-03-05
2019-09-30$257.04M
10-Q · filed 2019-11-12
2019-06-30$261.63M
10-Q · filed 2019-08-08
2019-03-31$259.45M
10-Q · filed 2019-05-07
2018-12-31$238.60M
10-K · filed 2020-03-02
2018-09-30$268.79M
10-Q · filed 2018-11-01
2018-06-30$273.94M
10-Q · filed 2018-08-07
2018-03-31$249.30M
10-Q · filed 2018-05-10
2017-12-31$270.06M
10-K · filed 2019-02-28
2017-09-30$266.89M
10-Q · filed 2017-11-08
2017-06-30$220.18M
10-Q · filed 2017-08-09
2017-03-31$224.82M
10-Q · filed 2017-05-08
2016-12-31$214.32M
10-K · filed 2018-02-26
2016-09-30$146.72M
10-Q · filed 2016-11-09
2016-06-30$149.37M
10-Q · filed 2016-08-09
2016-03-31$128.70M
10-Q · filed 2016-05-10
2015-12-31$124.61M
10-K · filed 2017-03-15
2015-09-30$122.22M
10-Q · filed 2015-11-12
2015-06-30$121.03M
10-Q · filed 2015-08-11
2015-03-31$129.93M
10-Q · filed 2015-05-15
2014-12-31$50.09M
10-K · filed 2016-02-29
2014-09-30$53.41M
10-K · filed 2016-02-29
2014-06-30$58.16M
10-Q · filed 2014-08-11
2014-03-31$63.96M
10-Q · filed 2014-05-15
2013-09-30$18.10M
10-K · filed 2014-12-22
$18.10M
10-Q · filed 2014-05-15